Functional Status, Morbidity and Mortality in Cemented Versus Press-Fit Hemiarthroplasty
2 other identifiers
interventional
130
1 country
1
Brief Summary
Hemiarthroplasty (half of a hip replacement) is the most common treatment for displaced fractures of the femoral neck in the elderly and is associated with a better functional outcome and fewer reoperations than internal fixation. Currently, the operative management of displaced femoral neck fractures favors the use of cemented implants. This technique is believed to be more stable in the immediate post-operative period, but there is limited evidence of a decreased morbidity and mortality with cemented versus press-fit stems (uncemented). In 2006, a meta-analysis concluded that the evidence was too limited to recommend a cemented or press-fit hemiarthroplasty. In this investigation, the morbidity, mortality and functional outcome associated with cemented and press-fit hemiarthroplasty will be compared prospectively. We propose that the use of press-fit hemiarthroplasty in the treatment of displaced subcapital fractures of the femoral neck would be associated with a decreased risk of adverse peri-operative outcomes, and that the functional results of cemented and press-fit hemiarthroplasty will be equivalent at one year.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2005
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2009
CompletedFirst Submitted
Initial submission to the registry
April 29, 2010
CompletedFirst Posted
Study publicly available on registry
May 3, 2010
CompletedResults Posted
Study results publicly available
August 7, 2018
CompletedAugust 7, 2018
March 1, 2013
4.2 years
April 29, 2010
March 21, 2013
July 31, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Mortality
Assessment of post-operative mortality at one-year.
1 year
Post-Operative Unstable Angina
Unstable angina was defined as the new onset of prolonged chest pain (greater than or equal to 30 minutes) or two episodes of chest pain thought to be of cardiac origin or an electrocardiogram showing new T-wave inversion, ST depression or elevation with enzymes non-diagnostic of myocardial ischemia.
1 week post-operation
Post-Operative Myocardial Infarction
Myocardial infarction required a positive troponin or electrocardiogram consistent with definite infarction.
1 week post-operation
Secondary Outcomes (2)
Instrumental Activities of Daily Living (IADL) and Physical Activities of Daily Living (PADL) Scale
1 year
Energy/Fatigue Scale
1 year
Study Arms (2)
Cemented Hip Hemiarthroplasty
OTHERThis arm received a hemiarthroplasty with a cemented femoral prosthesis (VerSys LD/Fx, Zimmer, Warsaw, IN).
Press-Fit Hip Hemiarthroplasty
EXPERIMENTALThis arm received a press-fit hemiarthroplasty (VerSys Beaded FullCoat, Zimmer, Warsaw, IN),
Interventions
The cemented femoral prosthesis is a VerSys LD/Fx, Zimmer, Warsaw, IN.
The press-fit component is a VerSys Beaded FullCoat, Zimmer, Warsaw, IN,
Eligibility Criteria
You may qualify if:
- older than 55 years
- non-pathologic, displaced subcapital femoral neck fracture
- designated for surgical reconstruction with a hemiarthroplasty by the attending surgeon
- able to ambulate ten feet prior to presentation
You may not qualify if:
- unable to walk ten feet prior to hip fracture
- multiple extremity trauma
- pathologic fracture of the hip (including malignancy)
- clinically recognized acute myocardial infarction within thirty days prior to enrollment
- previously participated in the trial
- symptoms associated with anemia
- pre-existing metabolic bone disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hartford Hospitallead
- Zimmer Biometcollaborator
Study Sites (1)
Hartford Hospital
Hartford, Connecticut, 06106, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Arben Ademi, CCRP
- Organization
- Hartford Hostpial
Study Officials
- STUDY DIRECTOR
Joseph P. DeAngelis, MD
Hartford Hospital
- PRINCIPAL INVESTIGATOR
Courtland G. Lewis, MD
Hartford Hospital
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 29, 2010
First Posted
May 3, 2010
Study Start
March 1, 2005
Primary Completion
May 1, 2009
Study Completion
May 1, 2009
Last Updated
August 7, 2018
Results First Posted
August 7, 2018
Record last verified: 2013-03